Dr. Zandberg is a translational and clinical researcher. His primary interest is the development of novel immunotherapy trials to improve outcomes in recurrent/metastatic squamous cell carcinoma of the head and neck.
Dr. Zandberg's clinical interests include head and neck and thyroid cancers as well as cutaneous squamous cell carcinoma of the head and neck
- BA, University of Delaware, 2001
- MD, Jefferson Medical College, 2005
- Residency, George Washington University Medical Center, 2008
- Fellowship, Hematology/Oncology, University of Maryland, 2012
Education & Training
Zandberg, DP, Strome SE. The role of the PD-L1:PD-1 pathway in squamous cell carcinoma of the head and neck. Oral Oncology. 2014; 50(7): 627-32.
Zandberg, DP, Bhargava, R, Badin, S, Cullen, KJ. The role of human papillomavirus in nongenital cancers. CA Cancer J Clin. 2013 Jan;63(1):57-81. CA: A Cancer Journal for Clinicians. 2013; 63(1): 57-81.
Zandberg, DP, Liu, S, Goloubeva, O, Schumaker LM, Cullen KJ. Emergence of HPV16 positive oropharyngeal cancer in black patients over time: University of Maryland 1992-2007. Cancer Prevention Research. 2015; 8(1): 12-9.
Zandberg DP, Rollins S, Goloubeva O, Morales RE, Tan M, Taylor R, Wolf JS, Schumaker LM, Cullen KJ, Zimrin A, Ord R, Lubek JE, Suntharalingam M, Papadimitriou JC, Mann D, Strome SE, Edelman MJ. A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN). Cancer Immunology Immunotherapy. 2015; 64(3): 367-79.
Liu SZ, Zandberg DP, Schumaker LM, Papadimitriou JC, Cullen KJ. Correlation of p16 expression and HPV type with survival in oropharyngeal squamous cell cancer. Oral Oncology. 2015; 51(9): 862-9.
Zandberg DP, Liu S, Goloubeva O, Ord R, Strome SE, Suntharalingam M, Taylor R, Morales RE, Wolf JS, Zimrin A, Lubek JE, Schumaker LM, Cullen KJ. Oropharyngeal cancer (OPC) drives racial outcome disparities in squamous cell carcinoma of the head and neck (HNSCC): Ten-year experience at the university of maryland greenebaum cancer center (UMGCC). Head & Neck. 2016; 38(4): 564-72.
Pai, SI, Zandberg, DP, Strome, SE. The role of antagonists of the PD-1:PD-L1/PD-L2 axis in head and neck cancer treatment. Oral Oncology. 2016; 61: 152-8.
Varki V, Ioffe OB, Bentzen SM, Heath J, Cellini A, Feliciano J, Zandberg DP. PD-L1, B7-H3, and PD-1 expression in immunocompetent versus immunosuppressed patients with cutaneous squamous-cell carcinoma. Cancer Immunology Immunotherapy. 2018; 67(5): 805-814.
- Member, American Association for Cancer Research (AACR), 2011-present
- Member, American Society of Clinical Oncology (ASCO), 2011-present
- NCI Calabresi Scholar Award, 2012
- Alliance Scholar Award, 2018
- Member, Society for Immunotherapy in Cancer (SITC), 2018-present
- NCI Cancer Clinical Investigator Team Leadership Award (CCITLA), 2019
- Leo H. Criep, MD Excellence in Patient Care Award, 2019-2020
- Castle Connolly Regional Top Doctor 2020, 2020
- Castle Connolly Regional Top Doctor 2021, 2021
- Pittsburgh Magazine Top Doctor, 2021
